Stay updated with breaking news from Josephine Hellschlienger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Total revenue of $7 million, compared to $101 million in Q3 2022Total cumulative partnered program starts of 110, up 20% from Q3 2022Net loss of $0.10 per share on a basic and diluted basis, compared to net earnings of $0.09 and $0.08 per share on a basic and diluted basis, respectively, in Q3 2022VANCOUVER, British...
Multi-year collaboration to jointly discover, develop, and commercialize novel oncology medicines for up to five programs, with the first ADC program focusing on a SMARCA degraderWILMINGTON, Del. & VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--Prelude Therapeutics Incorporated (“Prelude”) (Nasdaq: PRLD) and A...
VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) will announce its third quarter 2023 financial results on Thursday, November 2, 2023, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.A live audio webcast of the earnings conference may...
VANCOUVER, British Columbia —
PTAB rejects request by Berkeley Lights to reconsider its decision denying Berkeley's argument that AbCellera’s U.S. patent is invalidVANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) announced that the United States Patent and Trademark Office’s (USPTO) Patent Trial and Appeal Board (PTA...